These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2418385)

  • 1. [Therapeutic usefulness of propafenone in threatening ventricular extrasystolic arrhythmias controlled with Holter ECG].
    Ferrara E; Vitali A; Cucchi GF
    Minerva Cardioangiol; 1985 Sep; 33(9):553-6. PubMed ID: 2418385
    [No Abstract]   [Full Text] [Related]  

  • 2. [Holter analysis of ventricular arrhythmias and its treatment with propafenone].
    Peralta Heredia R
    Arch Inst Cardiol Mex; 1986; 56(3):225-30. PubMed ID: 2428317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Propafenone in ventricular hyperkinetic arrhythmias. Dynamic ECG evaluation of the acute oral test and short-term treatment].
    Garimoldi M; Sghirinzetti M; Pirastu A; Cappiello E; Sala R; Terranova P
    G Ital Cardiol; 1986 Apr; 16(4):328-32. PubMed ID: 2427383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oral propafenone in chronic ventricular arrhythmias. Prospective evaluation with the Holter monitor].
    Sánchez Domínguez J; Roldán I; Navarro A; Villa JG; Urbina FJ; Barciela R; Barras C
    Rev Clin Esp; 1985 Nov; 177(8):372-5. PubMed ID: 3836459
    [No Abstract]   [Full Text] [Related]  

  • 5. [Significance of cardiac arrhythmias in the aged and their treatment with propafenone controlled by plasma level].
    Lachnit KS; Rieder L
    Z Gerontol; 1985; 18(6):343-52. PubMed ID: 2420079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of propafenon in the control of ventricular extrasystolic arrhythmia. Clinical, electrocardiographic and laboratory evaluation in prolonged use].
    Giannini SD; Zillioto EE; Campanari JC; Formicola A
    Arq Bras Cardiol; 1980 Dec; 35(6):525-8. PubMed ID: 6167246
    [No Abstract]   [Full Text] [Related]  

  • 7. [Spontaneous variability of ventricular arrhythmias and evaluation of antiarrhythmic drug efficacy--studies evaluating the correlation between ventricular ectopic beat frequency and heart rate].
    Ito M; Tsumabuki S; Maeda Y; Arita M
    Rinsho Byori; 1986 Aug; 34(8):939-48. PubMed ID: 2431174
    [No Abstract]   [Full Text] [Related]  

  • 8. [Idiopathic ventricular tachyarrhythmia. Spontaneous variability and effect of various antiarrhythmic agents].
    Korsukewitz J; Wegscheider K; Schmutzler H
    Dtsch Med Wochenschr; 1985 Jul; 110(28-29):1103-7. PubMed ID: 2408842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of ventricular arrhythmias with propafenone].
    Petri H; Kafka W; Rudolph W
    Herz; 1985 Feb; 10(1):44-52. PubMed ID: 2579879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
    Geibel A; Zehender M; Hohnloser S; Landsrath C; Meinertz T; Just H
    Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of anti-arrhythmia agents].
    Klein G; Wirtzfeld A; Schlegl J; Himmler C; Neiss A
    Med Klin; 1980 Nov; 75(24):853-5. PubMed ID: 6160379
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experiences with a new anti-arrhythmia agent propafenon].
    Seipel L; Fischer G; Wiebringhaus E
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1229-31. PubMed ID: 70898
    [No Abstract]   [Full Text] [Related]  

  • 13. [Propafenon in ventricular arrhythmia caused by ischemic cardiopathy. Quantitative study using the Holter system].
    de Brito FS; Pereira MH; Castro I; Maia IG
    Arq Bras Cardiol; 1979 Oct; 33(4):303-10. PubMed ID: 94993
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)].
    Klempt HW; Nayebagha A; Fabry E
    Z Kardiol; 1982 May; 71(5):340-9. PubMed ID: 6180562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasma level and effectiveness of propafenone and its organ distribution (author's transl)].
    Blanke H; Aschbrenner B; Karsch KR; Kreuzer H
    Dtsch Med Wochenschr; 1979 Apr; 104(16):587-91. PubMed ID: 86416
    [No Abstract]   [Full Text] [Related]  

  • 16. [Oral propafenone in the long-term treatment of chronic ventricular arrhythmia].
    Vázquez García A; Marcos Sánchez F; Górgolas Hernández-Mora P; Durán Pérez-Navarro A
    Rev Clin Esp; 1986 Jun; 179(2):101. PubMed ID: 3738054
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of short-term drug testing as part of a systematic approach for evaluation of antiarrhythmic drugs.
    Podrid PJ; Lown B; Graboys TB; Lampert S
    Circulation; 1986 Feb; 73(2 Pt 2):II81-91. PubMed ID: 3943177
    [No Abstract]   [Full Text] [Related]  

  • 18. [The treatment of arrhythmias in infants and children using propafenone].
    Dressler F; Grävinghoff L; Grütte E; Jüngst BK; Liersch R; Nomayo H; Puls I; Rautenburg HW; Schmaltz A; Schumacher G
    Monatsschr Kinderheilkd; 1985 Mar; 133(3):154-7. PubMed ID: 4010670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term treatment with the new antiarrhythmic drug propafenone in correlation to plasma levels (author's transl)].
    Wiebringhaus E; Seipel L; Breithardt G; Loogen F
    Z Kardiol; 1977 Nov; 66(11):625-32. PubMed ID: 22958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum concentration and AV-conduction time in oral treatment with propafenone during a several-days period (author's transl)].
    Meyer-Estorf G; Keller K; Beck OA; Hochrein H
    Z Kardiol; 1980 Jun; 69(6):417-20. PubMed ID: 6160684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.